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Abstract— The potential of PET imaging for pre-clinical 
studies will be fully realized only if repeatable, reliable and 
accurate quantitative analysis can be performed. The 
characteristic blurring of PET images due to positron range 
and non co-linearity, as well as random, pile-up and scatter 
contributions, that may be significant for fully 3D PET 
acquisitions of small animal, make it difficult their 
quantitative analysis. In this work specific activity versus 
specific counts in the image calibration curves for 3D-OSEM 
reconstructions from a commercially available small animal 
PET scanner are determined. Both linear and non-linear 
calibration curves are compared and the effect of 
corrections for random and scatter contributions are 
studied. To assess the improvement in the calibration 
procedure when scatter and random corrections are 
considered, actual data from a rat tumor pre- and post- 
cancer therapy are analyzed. The results show that 
correcting for random and scatter corrections can increase 
the sensitivity of PET images to changes in the biological 
response of tumors by more than 15%, compared to 
uncorrected reconstructions.  
I. INTRODUCTION
There is growing evidence [1]-[4] that 18F-fluoro-2-
deoxyglucose (FDG) PET studies could have significant 
impact on the management of cancer patients. The 
evaluation of therapy response is usually done by 
computed tomography (CT), ultrasonography or magnetic 
resonance imaging (MRI). These imaging procedures 
allow the detection of changes in tumor size or volume, 
but do not provide tumor-specific functional information. 
The identification of (non-)responders to toxic treatment 
with these conventional techniques is far from optimal 
[5]-[8]. For example, it is difficult to distinguish residual 
disease from necrosis.  
PET imaging is able of disentangle differences in 
the metabolism of tissues. Thus, PET imaging with FDG 
is rapidly becoming a major tool in oncology because 
cancer cells have a much higher rate of glycolysis than 
                                               
Manuscript received November 15, 2007. 
 E.Vicente email: evicente@nuclear.fis.ucm.es,  
 M. Soto-Montenegro email: marisa@mce.hggm.es,  
 S. España e-mail: samuel@nuclear.fis.ucm.es, 
 J. L. Herraiz e-mail: joaquin@nuclear.fis.ucm.es. 
 E. Herrnaz e-mail: eherranz@nuclear.fis.ucm.es,  
 J.J.Vaquero email: juanjo@mce.hggm.es,  
 M. Desco e-mail: desco@mce.hggm.es; 
 J.M. Udias e-mail: jose@nuc2.fis.ucm.es 
non-neoplastic cells and therefore they have increased 
uptake of glucose and high signal on FDG-PET imaging.  
As functional changes are likely to precede anatomical 
ones, FDG PET could meet the need for timely and 
accurate non-invasive techniques that monitor response to 
therapy. 
The impact of FDG-PET imaging in cancer therapy 
effectiveness evaluation for preclinical studies depends 
on the availability of accurate data quantification. Indeed, 
response of lesions or tumors would only be assessed if 
the quantification of the reconstructed activity were stable 
with time and repeatable for different conditions of 
activity and rates and, correspondingly, different ratios of 
random and scatter counts.  
Typically, PET scanners exhibit a non flat activity 
versus count response, with two components: a linear one 
for which the count rate is linearly proportional to the 
activity in the field of view, as is the case of counts 
coming from ‘true’ and scatter coincidences and a 
nonlinear contribution, coming for instance from dead 
time and pile-up effects as well as random count 
contributions [9]. Assessing the importance of non-linear 
terms is essential for the calibration of the scanner. In this 
work , in order to estimate the contribution of non linear 
terms, linear and nonlinear specific activity versus specific 
counts in the image calibration curves for 3D-OSEM 
reconstructions of a commercial small animal PET 
scanner were obtained and Standard Uptake Values 
(SUV) were computed for two different reconstruction 
methods, one taking into account corrections for random, 
pile-up and scatter contributions and another without 
these corrections. The comparison of the results of these 
two methods would allow to disentangle whether these 
corrections in the reconstruction and calibration methods 
have any noticeable effect in the ability of PET images 
for determining changes in tumor activity. 
II. MATERIALS & METHODS
A. Scanner description 
Data from the high-resolution small animal rPET 
[10] scanner (SUINSA Medical Systems) were employed. 
This PET system has four detectors arranged in two 
orthogonal pairs which rotate 180º. Each detector 
comprises a single layer array of 30×30 MLS crystals 
(1.5×1.5×12 mm3) optically coupled to a Hamamatsu 
H8500 flat-panel PS-PMT.  
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The scanner has a ring diameter of 160 mm with 
effective transverse and axial field of view of 44.8 mm. 
The central point sensitivity at the center of the field of 
view (cFOV) is 2.1% (762.2 cps/μCi), the volumetric 
spatial resolution (in cFOV) is 3.4 mm3 and the average 
energy resolution is 17%. [11]. 
B. Calibration acquisitions and analysis 
Rat (5 cm diameter, 15 cm in length) and mouse 
(2.5 cm diameter, 7 cm in length) size cylinders were 
filled with FDG. The initial activity was known from an 
external independent calibration with a well-counter with 
accuracy of ±5. A total of 125 consecutive acquisitions of 
5 minutes were taken with both cylinders. This allowed 
spanning a large range of both specific activities per unit 
volume as well as global activity registered by the 
scanner. Both cylinder acquisitions were reconstructed 
with a 3D-OSEM procedure [11] with different 
assumptions. In one of them, there is no attempt to correct 
for random counts, scatter or pile-up in the acquisition 
data. In the other one (improved 3D-OSEM), corrections 
for randoms, scatter and pile-up are incorporated in the 
reconstruction algorithm [13]. 
After reconstruction, several regions of interest 
(ROIs) of different sizes were chosen in the interior of 
both cylinders and the specific counts per cubic 
centimeter and second (cps/cc) obtained from the 
reconstruction were compared against the known specific 
activity (uCi/cc) in the inner region of both cylinders. The 
data obtained from both cylinders was fit by 
i) a linear calibration curve, looking for the 
proportionality between the specific rate measured in 
the image and the specific activity known for each 
acquisition. A linear fit implicitly assumes that non 
linear effects (like random and pile-up contributions) 
can be neglected.  
ii)  a non linear fit that assumes that the specific 
measured rate can depend both on the specific activity 
and its square, for instance due to contribution of 
random counts. 
C. Rat acquisitions and analysis 
300 g rats with a subcutaneous tumor on the 
inguinal  area of around 150 mm3 in size (see Fig. 1 and 
Fig. 2) were injected with 2 mCi of FDG and scanned for 
15 minutes per bed (total studies have 2 or 3 beds) after 
one hour uptake. To prevent partial volume effects, a 
small region (from 0.013 to 0.15 mm3) well inside the 
tumor was considered  and the average specific activity 
(in uCi/cc) for this region was determined both prior to 
radiotherapy treatment and just a few days after therapy. 
In order to investigate whether dealing with corrections in 
the reconstruction and calibration methods has 
measurable effects in the PET capability of determining 
changes in tumor activity, standard uptake values (SUVs) 
[14]-[17] were computed as a measure of the biologically 
enhanced fixation of the radiotracer. To obtain 
dimensionless SUV values, the activity measured in the 
ROI is divided by the average specific activity 
determined from the ratio of the injected dose and the 
volume of the animal given by weight assuming unity 
density for the rat, that is: 
          
w/D
CSUV =   (1) 
being C (uCi/cc) the activity concentration in the ROI, D
(uCi) the injected dose corrected by uptake time and w (g)
the rat weight, using 1g/cc for the rat density.  
As it is well known [16],[17] variations in uptake 
values are often seen, due to differences in FDG uptake or 
uncertainties in the injected dose. In order to minimize 
these effects, uptake values were referenced to whole 
body (wb) uptake values, determined from the specific 
activity averaged over a ROI that spans the whole body of 
the rat. By definition, whole body uptake values should 
be unity, but variations around unity were observed 
depending on the acquisition and the 
calibration/reconstruction method employed. 
We also present SUV values referenced to one of 
the testicles since it showed a homogenous FDG 
distribution that was not influenced by the treatment and 
was easily visible in all the images.
Fig. 1. PET images of a rat with tumor reconstructed with 3D-OSEM. 
Left: Baseline scan (pre-radiotherapy image of the tumor). 
Right: Follow-up scan (image of the rat tumor five days after 
therapy). 
Fig. 2. PET images of the same rat with tumor of Fig. 1 reconstructed 
with the improved 3D-OSEM code. Left: Baseline scan (pre-
radiotherapy image of the tumor). Right: Follow-up scan 
(image of the tumor rat five days after therapy). 
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III. RESULTS AND DISCUSSION 
A. Calibration fits  
The difference of the results of the linear fit from 
the non-linear (quadratic) one was computed for both 
reconstruction methods. We obtained deviations of 11% 
for the standard 3D-OSEM procedure and 5% for the 
improved 3D-OSEM. Fig. 3 shows the quadratic fit (non-
linear fit, green line) and the linear one (linear fit 1, 
yellow line) computed from the whole calibration data 
range and another linear fit (linear fit 2, red line) 
calculated from activity concentrations smaller than 63 
uCi/cc, corresponding to the maximum range of tumor 
data. The parameters of all of fits are quoted in table I. 
The larger values of the coefficients for the improved 3D-
OSEM method are due to the fact that a smaller number 
of counts survive in the image compared to the standard 
reconstruction, after the (iterative) removal of, mostly, 
detector scatter counts [13]. 
TABLE I
PARAMETERS OF CALIBRATION FITS 
?
?
?
=
=
+=
(uCi/cc)[Y]
(cps/cc)[X]
·XA·XAY 221
3D-OSEM Improved 3D-OSEM 
Fit A1
(uCi/cps) 
A2
(uCi·cc/cps2)
A1
(uCi/cps) 
A2
(uCi·cc/cps2)
Non-
linear 1.67·10
-4 1.48·10-11 1.07·10-3 3.30·10-10
Linear 1 1.50·10-4  1.07·10-3  
Linear 2 1.63·10-4  1.04·10-3  
                                   Count rate (cps/cc)                            Count rate (cps/cc)
(a) (b) 
Fig. 3. Linear and non-linear fits for 3D-OSEM (a) and improved 3D-OSEM (b) reconstruction methods: Counts per cubic centimeter and second 
(cps/cc) vs. activity concentration. The actual range of tumor data lies in between the blue vertical thick bars (see zoom of this region in the 
small insert).  
In Fig. 3 (a) (3D-OSEM) we can see that the linear 
fit 1 does a good job for the higher activity concentrations 
but not so much for the lower ones. Linear fit 2 seems 
more suitable for lower concentrations (<63 uCi/cc), 
where our tumor data are distributed. Differences 
between the quadratic fit and the linear fit 2 (for the 
reduced range of activity concentrations) are about 2%. 
Fig. 3 (b) (improved 3D-OSEM) shows that there are not 
significant differences between both linear fits in this 
case. In what follows we present only SUV values 
obtained from the linear calibration fit 2, that uses only 
data within the range were our tumor data are distributed, 
activity concentrations below 63 uCi/cc. SUV values 
were also calculated with the nonlinear (quadratic) 
calibration but the deviations between results obtained 
with both calibrations for all images and reconstruction 
methods were smaller than 0.5% for the SUV ratios and 
2-5% for the SUV values.  
B. SUVs computation 
Count rate for the acquired rat data varied from 8 to 
50 kcps depending on the particular acquisition. Specific 
rates on the reconstructed images ranged from 20 to 95 
kcps/cc (3D-OSEM) or 6 to 19 kcps/cc (improved 3D-
OSEM) for the different acquisitions and regions of the 
image. These values are well within the range of the 
calibration data acquired as we can see in Fig. 3.  
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TABLE II
STANDARD UPTAKE VALUES FOR 3D-OSEM METHOD
tumorSUV wbSUV testicleSUV wbSUV
SUVtumor
testicle
tumor
SUV
SUV
D1 4.15 0.73 1.03 5.67 4.02 
Rat 1
?
?
?
D2 3.27 
(-21%)
0.94 
(28%)
1.28
(24%)
3.48
(-39%)
2.55 
(-37%)
D1 3.56 0.88 1.29 4.06 2.75 
Rat 2
?
?
?
D2 1.69 
(-53%)
0.46 
(-47%)
0.84
(-35%)
3.65
(-10%)
2.01 
(-27%)
D1 1.99 0.63 1.02 3.17 1.95 
rat 3
?
?
?
D2 1.57 
(-21%)
0.45 
(-28%)
0.75
(-26%)
3.45
(9%)
2.08 
(7%)
TABLE III
STANDARD UPTAKE VALUES FOR IMPROVED 3D-OSEM METHOD
tumorSUV wbSUV testicleSUV wbSUV
SUVtumor
testicle
tumor
SUV
SUV
D1 7.32 1.05 1.60 6.97 4.58 
Rat 1
?
?
?
D2 4.14 
(-43%)
1.12
(7%)
1.83
(15%)
3.70
(-47%)
2.26 
(-51%)
D1 5.44 1.16 1.81 4.67 3.01 
Rat 2
?
?
?
D2 2.70 
(-50%)
0.54
(-54%)
1.17
(-35%)
5.04
(8%)
2.30 
(-24%)
D1 3.43 0.83 1.59 4.15 2.16 
rat 3
?
?
?
D2 2.24 
(-35%)
0.56
(-33%)
1.17
(-27%)
4.03
(-3%)
1.92 
(-11%)
Results for tumorSUV , wbSUV and testicleSUV  values 
and the ratios wbSUVSUVtumor  and testicletumor SUVSUV  are 
presented in tables II and III. Relative variations pre-post 
therapy of the SUV values (shown inside round 
parenthesis in the tables) were also computed with the 
following expression:  
          ( ) ( )( ) 1001DSUV
1DSUV2DSUV? ×−=   (2) 
The results obtained for the  testicletumor SUVSUV
ratios are also plotted in Fig. 4. 
SUV tumor/SUV testicle
-
0,5 
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5,0 
OSEM3D Improved OSEM3D
Rat 1 (D1)
Rat 1 (D2)
Rat 2 (D1)
Rat 2 (D2)
Rat 3 (D1)
Rat 3 (D2)
Fig. 4. SUV(tumor) / SUV(testicle) measured ratios on 3D-OSEM and 
improved 3D-OSEM methods. SUV values of pre-therapy day 
(D1) and post-therapy day (D2) are shown. 
IV. CONCLUSIONS
From the results presented in Fig. 3 and 4 and tables 
II and III, it is clearly seen that:  
I) On average, both OSEM3D and improved OSEM3D 
PET images are able to assess positive response of 
tumor to treatment. 
II) Linear and non linear calibrations yield essentially 
identical results for the improved 3D-OSEM images, 
with differences smaller than 5% for the SUV values 
and than 0.5% for the SUV ratios. This indicates the 
ability of the improved reconstruction of reducing 
non-linear contributions to the scanner response. 
III) A linear calibration is suitable for 3D-OSEM even 
when no random, scatter and pile-up corrections are 
incorporated provided that the analysis is restricted to 
moderate values of activity (< 60 muCi/cc in our case) 
were quadratic terms are less important. This reduces 
the deviations of linear and non-linear fits from 11% 
(when linear fit is computed from the whole 
calibration data range) to 2% (when linear fit is 
calculated from low activity concentrations) for the 
SUV values and inferior to 0.5% for the SUV ratios. 
IV) The ratio of testicletumor SUVSUV  seems to be appropriate 
for assessing the response of tumors to treatment. 
V) The improved OSEM method might provide enhanced 
lesion recovery. Changes induced by therapy in 
4
SUV(tumor)/SUV(testicle) values appear 10% larger, 
in the average of the three rats, for improved OSEM 
with respect to standard OSEM. This is in accordance 
with previous studies on phantoms that also showed 
increased contrast and larger recovery coefficients for 
the improved 3DOSEM reconstruction [13]. 
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